AI-generated summary
The authors report a mouse study in which low-level laser therapy applied to bone marrow was given weekly for two months to 5XFAD Alzheimer's model mice starting at four months of age. Treated mice showed improved memory and spatial learning and a reduced brain amyloid burden compared with sham-treated mice, and the authors suggest this approach as a potential therapy in progressive disease stages. The study is a minireview of animal and cell work, so its findings are preclinical.
- Who or what was studied
- 5XFAD transgenic male mice (Alzheimer's disease model) and wild-type mice for in vitro cell work
- Limits stated in the abstract
- The findings come from animal and in vitro cell studies, and the abstract does not report a human sample or a sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.